Sqz Biotechnologies Company (SQZB)

$0.03 0.00 (N/A)
Market Cap 826,000.00
Revenue (ttm) 21.48M
Net Income (ttm) -79.46M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -369.93%
Debt to Equity Ratio 0.00
Volume 5,000
Avg Vol 19,718
Day's Range N/A - N/A
Shares Out 29.49M
Stochastic %K 0%
Beta 1.37
Analysts Strong Buy
Price Target $22.00

Company Profile

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 758 8672
Address:
200 Arsenal Yards Boulevard, Suite 210, Watertown, United States
colenegolab
colenegolab Apr. 4 at 1:25 PM
🚨 Don’t Miss Out on MY_N-Z 🚨 $SQZB Main z Biomed kicked off a 2,000-patient trial for its next-gen colorectal cancer test — combining mRNA tech + AI to detect cancer before it starts. Why buy MY_N-Z now? ✅ Game-changing early detection = huge market potential ✅ Top-line results in Q4 2025 = massive upside ✅ U.S. pivotal trial next = momentum building fast 📈 Lab network revenue increased by 33% year over year. 📉Operating loss decreased by 30% and net loss by 18%. 🤝 New partnerships with Thermo Fisher, Quest Diagnostics, and Liquid Biosciences 💡Key moments: 📊ASCO 2024: Key colorectal cancer data and 🏆DDW 2024: Poster of Distinction for eAArly DETECT This is a rare early-stage biotech with real traction. Get in before Wall Street wakes up. ⏳🔥
0 · Reply
27R
27R Mar. 19 at 4:51 PM
$SQZB's upcoming earnings release draws attention amid high expectations. Recent price volatility and elevated options activity suggest traders anticipate material moves. Key metrics will likely drive sentiment, with focus on margin trends and guidance. Institutional positioning remains balanced, highlighting a potential inflection point.
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Oct. 8 at 8:27 PM
$SQZB
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Sep. 30 at 1:28 AM
$SQZB One dollar soon
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Aug. 19 at 8:51 PM
$SQZB
0 · Reply
Freccia
Freccia Apr. 18 at 12:16 PM
$SQZB SQZ lab closed down a few months ago. I don’t even know why this is here, take the rest of your money and put somewhere else
0 · Reply
Sholton
Sholton Mar. 20 at 4:53 PM
$SQZB any new information on this ?
1 · Reply
Mstaha
Mstaha Feb. 5 at 7:08 PM
$SQZB we are coming to the end of the road
0 · Reply
Mstaha
Mstaha Jan. 31 at 7:47 PM
$SQZB I have a loss of $10K with a cost of $1. I'm just hanging out
0 · Reply
ross929
ross929 Jan. 29 at 8:24 PM
$SQZB if you read the company’s most recent filing, they estimate the asset purchase will return $.0368 per share to shareholders.
2 · Reply
Latest News on SQZB
No data available.
colenegolab
colenegolab Apr. 4 at 1:25 PM
🚨 Don’t Miss Out on MY_N-Z 🚨 $SQZB Main z Biomed kicked off a 2,000-patient trial for its next-gen colorectal cancer test — combining mRNA tech + AI to detect cancer before it starts. Why buy MY_N-Z now? ✅ Game-changing early detection = huge market potential ✅ Top-line results in Q4 2025 = massive upside ✅ U.S. pivotal trial next = momentum building fast 📈 Lab network revenue increased by 33% year over year. 📉Operating loss decreased by 30% and net loss by 18%. 🤝 New partnerships with Thermo Fisher, Quest Diagnostics, and Liquid Biosciences 💡Key moments: 📊ASCO 2024: Key colorectal cancer data and 🏆DDW 2024: Poster of Distinction for eAArly DETECT This is a rare early-stage biotech with real traction. Get in before Wall Street wakes up. ⏳🔥
0 · Reply
27R
27R Mar. 19 at 4:51 PM
$SQZB's upcoming earnings release draws attention amid high expectations. Recent price volatility and elevated options activity suggest traders anticipate material moves. Key metrics will likely drive sentiment, with focus on margin trends and guidance. Institutional positioning remains balanced, highlighting a potential inflection point.
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Oct. 8 at 8:27 PM
$SQZB
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Sep. 30 at 1:28 AM
$SQZB One dollar soon
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Aug. 19 at 8:51 PM
$SQZB
0 · Reply
Freccia
Freccia Apr. 18 at 12:16 PM
$SQZB SQZ lab closed down a few months ago. I don’t even know why this is here, take the rest of your money and put somewhere else
0 · Reply
Sholton
Sholton Mar. 20 at 4:53 PM
$SQZB any new information on this ?
1 · Reply
Mstaha
Mstaha Feb. 5 at 7:08 PM
$SQZB we are coming to the end of the road
0 · Reply
Mstaha
Mstaha Jan. 31 at 7:47 PM
$SQZB I have a loss of $10K with a cost of $1. I'm just hanging out
0 · Reply
ross929
ross929 Jan. 29 at 8:24 PM
$SQZB if you read the company’s most recent filing, they estimate the asset purchase will return $.0368 per share to shareholders.
2 · Reply
EarningsInsider
EarningsInsider Jan. 25 at 2:45 PM
SQZ Biotechnologies Sees Short Interest Decrease from 88,500 shares to 27,700 shares. $SQZB https://www.marketbeat.com/stocks/OTCMKTS/SQZB/
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jan. 23 at 4:26 PM
$SQZB Rats are going to start crawling out everywhere now. Lawyering up https://www.law.com/texaslawyer/2023/10/16/1-of-texas-busiest-judges-just-resigned-over-a-romance-with-a-lawyer/
1 · Reply
Mstaha
Mstaha Jan. 18 at 2:44 AM
$SQZB april.
1 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jan. 17 at 6:51 PM
$SQZB
0 · Reply
Sholton
Sholton Jan. 9 at 5:22 PM
$SQZB Is this dead now. It’s not moving or showing up on charts
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jan. 5 at 2:28 AM
$SQZB Anyone left besides me and the crickets?
1 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Jan. 2 at 2:43 PM
$SQZB
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 28 at 4:12 AM
$SQZB
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 23 at 3:11 AM
$SQZB Hey bears we know you live in the shadows but we just got bought. If they assume all our debt per the 8k we longs get 2.50 a share. Guess that’s where you cover at now. Merry Christmas
2 · Reply